LEXINGTON, KY — November 11, 2025 — Demeetra AgBio announced that its flagship CleanCut GS CHO cell line has tested clean on two independent viral safety panels—the IDEXX IMPACT and Charles River Labs Extended CLEAR panels—demonstrating full viral clearance and confirming the cells’ readiness for GMP-level biomanufacturing. Engineered using Demeetra’s Cas-CLOVER precision gene-editing system, CleanCut GS CHO combines high editing efficiency, ultra-low off-target activity, and proven genomic stability to deliver high-productivity, authenticated host cells for biologics manufacturing. As the first GMP-ready product in Demeetra’s CleanCut portfolio, the cell line offers a reliable and accessible platform for biopharma, biotech, and CDMO partners.

Demeetra provides integrated genome engineering platforms, and products, backed by deep technical expertise.

Contact us to learn how our differentiated IP, flexible access models, and internal know-how can support adoption from discovery through bioprocessing and commercial use.

Buy Products
Schedule A Call